Werfen Displays Complete Solutions for Hemostasis, Acute Care, Transfusion, and Transplant Solutions
Posted on 28 Jul 2026
At ADLM 2026, Werfen is highlighting a broad portfolio of diagnostic technologies across two exhibit spaces at the Anaheim Convention Center. Visitors to booths 2937 and 3129 can explore instruments, reagents, automation, and digital solutions for hemostasis, acute care, transfusion medicine, autoimmunity, and transplant diagnostics.
In hemostasis, Werfen is showcasing the new ACL TOP Family 70 Series, designed to standardize testing while expanding automation, connectivity, and analytical performance. The systems are supported by the HemosIL portfolio of liquid, ready-to-use routine and specialty reagents, along with HemoCell Specialized Lab Automation and HemoHub Intelligent Data Manager for centralized workflow management.
The company’s acute care display includes the GEM Premier 7000 with iQM3. The blood gas system incorporates point-of-care hemolysis detection to help identify a major source of preanalytical error. Werfen is also presenting the ROTEM sigma cartridge-based thromboelastometry system, which provides rapid results to support bleeding-management decisions.
For transfusion medicine, the exhibit features ImmuLINK, a digital solution that applies a full algorithm to complex antibody-identification workflows. The platform is designed to improve the speed, consistency, and confidence of laboratory interpretation while reducing reliance on manual decision-making.
Werfen is additionally highlighting its Integrated Lab+ solution for autoimmune diagnostics. The portfolio combines testing systems, reagents, automation, and digital connectivity to help laboratories improve workflow efficiency and provide clinicians with information for diagnosing and managing autoimmune diseases.
In transplant diagnostics, the company is presenting MatchX, a digital platform supporting HLA antibody, HLA typing, and platelet antibody workflows. Its interface allows laboratories to review and compare complex data while supporting expert interpretation and more efficient reporting.
Other transplant solutions include NanoTYPE HLA-11 Plus, which provides full-gene HLA genotyping across all 11 classical loci using Oxford Nanopore Technologies long-read sequencing platforms. Werfen is also featuring the LIFECODES Single Antigen Class I and Class II Enhanced LSA Assays, designed to improve specificity, reduce false-positive results, and help laboratories identify acceptable organ donors.
Visitors can explore Werfen’s automation systems through an immersive virtual-reality laboratory experience and attend in-booth workshops covering quality control, heparin-induced thrombocytopenia, autoimmune testing, hemophilia, point-of-care hemolysis detection, anticoagulation monitoring, and patient blood management.
